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Abstract
Background: The aim of the present study was to determine the best anthropo-
metric discriminators of type 2 diabetes mellitus (T2DM) among White and
Black males and females in a large US sample.
Methods: We used Atherosclerosis Risk in Communities study baseline data
(1987–89) from 15 242 participants (1827 with T2DM) aged 45–65 years.
Anthropometric measures included a body shape index (ABSI), body adiposity
index (BAI), body mass index, waist circumference (WC), waist: height ratio
(WHtR), and waist: hip ratio (WHR). All anthropometric measures were
standardized to Z-scores. Using logistic regression, odds ratios for T2DM were
adjusted for age, physical activity, and family history of T2DM. The Akaike
information criterion and receiver operating characteristic C-statistic were used
to select the best-ﬁt models.
Results: Body mass index, WC, WHtR, and WHR were comparable discrimina-
tors of T2DM among White and Black males, and were superior to ABSI and
BAI in predicting T2DM (P< 0.0001). Waist circumference, WHtR, and WHR
were the best discriminators among White females, whereas WHR was the best
discriminator among Black females. The ABSI was the poorest discriminator of
T2DM for all race–gender groups except Black females. Anthropometric values
distinguishing T2DM cases from non-cases were lower for Black thanWhite adults.
Conclusions: Anthropometric measures that included WC, either alone or
relative to height (WHtR) or hip circumference (WHR), were the strongest
discriminators of T2DM across race–gender groups. Body mass index was a
comparable discriminator to WC, WHtR, and WHR among males, but not
females.
Keywords: gender, obesity, race, type 2 diabetes.
Signiﬁcant ﬁndings of the study: Body mass index, WC, WHtR, and WHR were comparable anthropometric
discriminators of T2DM among White and Black males in the US, whereas WC, WHtR, and WHR were the best
discriminators among White females. The WHR was the best discriminator among Black females.
What this study adds: Anthropometric measures that included WC, either alone or relative to height (WHtR) or
hip circumference (WHR), were the strongest discriminators of T2DM across race–gender groups. Body mass
index was a comparable discriminator to WC, WHtR, and WHR among males, but not females.
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Introduction
The prevalence of type 2 diabetes mellitus (T2DM) has
more than tripled over the past 30 years, affecting 29.1
million Americans, which represents 9.3 % of the US
population.1 Type 2 diabetes mellitus is a major cause
of heart disease and stroke, and is the seventh leading
cause of death in the US. It is estimated that over 3.8
million Blacks (13.2 %) aged 20 years or older in the
US have diagnosed or undiagnosed T2DM.1 Several risk
factors are associated with T2DM and its complications,
including obesity, older age, family history of T2DM,
history of gestational diabetes, impaired glucose metabo-
lism, physical inactivity, and certain racial/ethnic
origin.2
Excess adiposity and the prevalence of obesity have
increased signiﬁcantly among US adults and youths
between 1999 and 2004.3 Visceral adipose tissue and, to
a lesser degree, subcutaneous abdominal adipose tissue
are hormonally active tissues known to be related to
the development of T2DM, metabolic syndrome, and
other cardiometabolic abnormalities.4 The mechanism
involves a release of excess fatty acids and inﬂammatory
cytokines into the portal circulation.5 Visceral adipose
tissue volume and the values associated with health risk
differ by race and gender.4,6–9 Whereas visceral adipose
tissue volume is greater in White men and women than
Black men and women in the US, subcutaneous adipose
tissue volume is lower in White men and women
compared with Black men and women after adjusting
for age, total body fat, smoking, and menopausal
status.8,9 Despite having relatively less visceral adipose
tissue and more muscle mass than Whites, Blacks have
a higher prevalence of insulin resistance, T2DM, and
cardiovascular disease.4,6
Anthropometric measures that are considered surro-
gates for visceral adipose and subcutaneous adipose
tissues are used to estimate abdominal obesity and subse-
quent T2DM disease risk10–13 and consequential prema-
ture mortality.14 The risk of T2DM increases with
general and central obesity and is decreased or prevented
with weight loss of 5%–7% of body weight.15 Anthropo-
metric measures are currently being used in medical
settings to screen for obesity-associated health risk. The
application of cost-effective and efﬁcient anthropometric
screening measures to assess T2DM risk may be useful
to identify patients who are in greatest need of preventive
treatment. In addition, characteristics such as race and
gender may determine which anthropometric measure-
ments are most useful to identify individuals at risk of
developing T2DM.
Two commonly used anthropometric measures are
body mass index (BMI) and waist circumference (WC),
both of which have their limitations. Bodymass index pro-
vides an estimate of general obesity, but does not distin-
guish between fat and muscle mass, and is a poor
discriminator of cardiovascular risk.16,17 Waist circum-
ference, a measure of central obesity that is highly corre-
lated with BMI,18 is associated with T2DM in various
populations,11,18–20 has varied cut-off values depending
on race and gender,16,19–21 and may over- or underesti-
mate T2DM risks in short or tall people.22 Visceral adi-
pose tissue and WC are better discriminators of
cardiometabolic risks than BMI, fat mass, and percent
body fat.7 Across levels of WC or BMI, women have
higher levels of subcutaneous adipose tissue volume than
men.4 Especially at higher levels of BMI andWC, visceral
adipose tissue is greater in White men and women than
Black men and women. Consequently, visceral adipose
tissue may play a bigger role in predicting cardiometabolic
risks inWhites than Blacks.4,8 At higher levels of BMI, fat
mass becomes reduced between Black American men and
women, whereas this difference is constant betweenWhite
men and women.8
Other anthropometric measures are waist: hip ratio
(WHR), a measure of WC divided by hip circumference,
and waist: height ratio (WHtR), computed as WC
divided by height.23 In Mexican Americans, WC is a bet-
ter discriminator than BMI or WHR when screening for
T2DM.24 Generally, WC, WHR, and WHtR are consi-
dered better discriminators of T2DM risk than BMI.25
Body adiposity index (BAI), calculated using hip circum-
ference and height, has been used as a risk indicator
among Mexican Americans and Black Americans.26 In
another study, BMI and BAI were similar at predicting
body fat and differed by sex, but only BMI differed by
race between Whites and Blacks.27 However, the disease
discrimination and validation of BAI is not known and
further research is warranted.
In an effort to address limitations of existing anthro-
pometric measures, Krakauer et al.28 developed a new
measure called A body shape index (ABSI) based on
WC, BMI, and height. In their studies,28,29 ABSI was
positively correlated with mortality among males and
females and across different age groups of White and
Black Americans28; ABSI was a better predictor of mor-
tality than WC, WHtR, and WHR over 20 years of
follow-up.29 Other studies report that ABSI is a weaker
predictor of cardiovascular disease mortality among
White Americans,30 cardiovascular disease risk factors
among Asians,11,31,32 and stroke risk among Spanish
European men.33 It is not known whether ABSI, BAI,
BMI, WC, WHtR, or WHR is the best discriminator
of T2DM in White and Black Americans. The aim of
the present study was to determine the predictive ability
of the anthropometric measures to discriminate T2DM
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in a large cross-sectional sample of middle-aged White
and Black males and females in the US.
Methods
Study sample of White and Black American adults
The study sample was drawn from the Atherosclerosis
Risk in Communities (ARIC) study, a large, ongoing,
prospective cohort study designed to investigate the
etiology of atherosclerosis and clinical outcomes of
approximately 16 000 American adults in four US com-
munities (Baltimore, MD; Minneapolis, MN; Jackson,
MI; and Winston-Salem, NC). Each ARIC ﬁeld center
randomly selected and recruited a cohort of approxi-
mately 4000 individuals aged 45–64 years from a deﬁned
population in their community between 1987 and 1989.
Baseline de-identiﬁed ARIC data from 15 242 partici-
pants were obtained from BioLINCC (https://biolincc.
nhlbi.nih.gov/home/, accessed 4 May 2016). Further
design and sampling methods are explained else-
where.34,35 All participants provided informed consent.
The present secondary data analysis was approved by
the Augusta University (formerly Medical College of
Georgia) Institutional Review Board.
Study variables
The outcome variable, T2DM, was deﬁned using the
American Diabetes Association criteria36 as the presence
of at least one the following: fasting blood glucose
(FBG) ≥126mg/dL, non-FBG ≥200mg/dL, self-report
of diabetes diagnosis, or self-report of taking diabetes
medications. The anthropometric measures included
ABSI, calculated as WC (m)/[BMI0.66×height (m)0.5];
BAI, calculated as hip circumference (cm)/[(height
(m)1.5) – 18]; BMI, calculated by dividing body weight
(kg) by height (m) squared; WC (cm); WHtR, calculated
by dividing WC (cm) by height (cm); and WHR, calcu-
lated by dividing WC (cm) by hip circumference (cm).
These predictor variables were examined separately in
their respective models. Measurements of body weight,
height, WC, and hip circumference were performed by
two trained ARIC technicians. If there was only one
technician, a full-length mirror was used to aid placement
of the tape measure. Participants were measured in the
fasted state, in light clothing without shoes. Weight was
measured using a digital scale (Model #437; Detecto,
Webb City, MO, USA) to the nearest 0.5 lb (0.23kg).
Height was measured with a stadiometer; WC was
measured using an anthropometric tape at the level of
the umbilicus, with the participant standing erect and
the position veriﬁed using an observer or mirror per stan-
dard ARIC protocol;37 hip circumference was measured
horizontally at the greatest level of protrusion of the
buttocks. Height, WC, and hip circumference were mea-
sured to the nearest cm.
The following participant characteristics were consid-
ered for covariate adjustment in multivariate logistic
regression analyses: age, gender, physical activity (com-
puted as physical activities at work + sport + leisure using
the Baecke physical activity index38), and family history of
T2DM (yes/no). Additional descriptive characteristics not
included in the data models were FBG (mg/dL), high-
density lipoprotein cholesterol (mg/dL), use of blood
pressure medications (yes/no), ever smoked cigarettes
(yes/no), alcohol intake (g/day), and highest education
level completed (less than high school, high school gra-
duate to some college or vocational school graduate, and
college graduate or higher).
Statistical analysis
Statistical analyses were conducted using Stata MP,
Version 14.0 (StataCorp, College Station, TX, USA).
Logistic regression was used for the univariate (anthro-
pometric discriminator and T2DM) and bivariate
(anthropometric discriminator adjusted for each covari-
ate on T2DM) analyses for males and females. The
covariates included age (5-year increments), physical
activity (Baecke units), and family history of diabetes
(yes/no). Similarly, multivariate associations of each
anthropometric measure adjusted for covariates were
determined. All anthropometric measures were stan-
dardized to Z-scores for each race–gender group using
the following equation:
Z-score= (individual anthropometric value – group
mean anthropometric value)/group SD.
Participants with missing observations (n=243) for
any variable were excluded in order to have a complete
dataset. Several models were explored; the most parsi-
monious models are presented in order to be able to
generalize our ﬁndings back to the parent White and
Black populations.
The Akaike information criterion (AIC) was used in
building the multivariate models. With the stepwise
addition of covariates to the model, the AIC values
decreased until the smallest AIC was achieved. The
receiver operating characteristic (ROC) curve was used
to evaluate the results of the AIC. The ROC curves were
constructed by regressing each anthropometric measure
with age, physical activity, and family history of diabetes
on T2DM in separate models, then assessing the ﬁt of the
model. The models with the highest ROC concordance
statistic (C-statistic) were chosen for each respective
anthropometric model in race–gender models. The
ROC curves were plotted by using the true positive rate
Anthropometric discriminators of T2DMD.S. Hardy et al.
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against the false positive rate for all anthropometric
multivariate models for White and Black males and
females separately. We further tested the equality of
ROC curves by testing whether two or more ROC areas
were close in discriminatory ability within race–gender
groups by examining the C-statistic and the P-value
from their respective tests. A C-statistic ≤0.5 indicates
no discrimination (i.e. the model is no better than chance
for predicting which individuals have T2DM), whereas
C-statistic values ≥0.7 and <0.8 are considered to indi-
cate acceptable discrimination, those ≥0.8 and <0.9 are
considered to indicate excellent discrimination, and
those ≥0.9 are considered to indicate outstanding
discrimination.39 In all analyses, two-tailed P< 0.05
was considered signiﬁcant. The case identiﬁer to distin-
guish T2DM cases from non-cases for each anthropo-
metric measure was calculated as the point on the ROC
curve that is farthest from the line of equality (reference
line).39,40
Results
Characteristics of the sample of White and Black
American adults
Descriptive characteristics for all American partici-
pants by race- and gender-speciﬁc stratiﬁcations are
presented in Table 1. The sample included 15 242
participants/1827 T2DM cases (5320/543 White
males, 1527/285 Black males, 5936/479 White females,
and 2459/520 Black females). The mean ABSI was
higher among Whites than Blacks. Mean BMI was
higher among Black females than White females (30.8
vs 26.6 kg/m2, respectively), and BAI and WHtR were
highest among Black females than other race–gender
groups. Behavioral characteristics revealed that the
mean Baecke physical activity scores were lowest for
Black males and highest for White males. Black males
and females had higher FBG than their White counter-
parts, which was mirrored in their diagnosis of T2DM.
Table 1 Descriptive characteristics of all American participants by gender and race
Range
Mean ± SD or percentage of sample
Whites males
(n=5320)
Black males
(n=1527)
White females
(n=5936)
Black females
(n= 2459)
Age (years) 45–64 54.8 ± 5.7 53.9 ± 6.0* 54.0 ± 5.7 53.3 ± 5.7†
Physical activity1 (Baecke units) 3–14 7.4 ± 1.4 6.4 ± 1.5* 6.9 ± 1.4 6.6 ± 1.4†
Family history of diabetes
(% of sample)
Yes/no 22.5 24.8 24.7 29.3†
Type 2 diabetes (% of sample) Yes/no 10.2 18.7* 8.1 21.2†
Fasting blood glucose (mg/dL) 35–628 108 ± 31 117 ± 52* 103 ± 32 120 ± 60†
HDL-C (mg/dL) 9.6–163 43 ± 12 51 ± 17* 57 ± 17 58 ± 18
Blood pressure medications
(% of sample)
Yes/no 20.3 34.5* 19.5 44.4†
Ever smoke cigarettes
(% of sample)
Yes/no 72.2 71.9 49.5 42.9†
Alcohol intake (g/day) 0–1856 71 ± 121 68 ± 145 24 ± 53 10.6 ± 41.3†
Education level (% of sample)
<High school Yes/no 18.0 44.1* 16.3 40.1†
High school or vocational
school graduate
Yes/no 39.3 26.3* 50.9 30.0†
≥College graduate Yes/no 42.7 29.6* 32.7 29.9†
Anthropometric measures
ABSI (m/(kg/m2)0.66 ×m0.5) 0.0404–0.1161 0.0827 ± 0.0032 0.0801 ± 0.0038* 0.0823 ± 0.0058 0.0801 ± 0.0038†
Body adiposity index
(cm/m1.5–18)
1.1–68.3 26.0 ± 3.5 26.0 ± 4.3 32.6 ± 5.7 35.2 ± 6.5†
BMI (kg/m2) 14–66 27.5 ± 4.0 27.5 ± 4.2 26.6 ± 5.5 30.8 ± 6.5†
Waist circumference (cm) 20–70 99.7 ± 10.5 97.0 ± 12.8* 93.2 ± 14.9 100.6 ± 16.3†
Waist: height ratio (cm/cm) 0.3–1.1 0.6 ± 0.1 0.6 ± 0.1* 0.6 ± 0.1 0.6 ± 0.1†
Waist: hip ratio (cm/cm) 0.5–1.4 1.0 ± 0.1 0.9 ± 0.1* 0.9 ± 0.1 0.9 ± 0.1†
*P< 0.0001 compared with White males; †P< 0.0001 compared with White females.
Descriptive statistics evaluated using Pearson Chi-squared tests of independence for categorical variables and t-tests for continuous variables.
The sample sizes for fasting blood glucose, high-density lipoprotein cholesterol (HDL-C), blood pressure medications, ever smoked cigarettes,
alcohol intake, and education level were as follows: White males, n = 5251; Black males, n = 1454; White females, n = 5886; and Black females
n = 2333.
1Physical activity reﬂects work + leisure + sport activities calculated from the Baecke questionnaire.38
ABSI, A body shape index; BMI, body mass index.
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Blood pressure medications were used by more Blacks
than Whites. More White and Black males had ever-
smoked cigarettes than White and Black females.
White and Black males had higher daily alcohol intake
than White and Black females. More Whites were
college educated than Blacks.
Univariate and bivariate associations between
anthropometric measures and T2DM
Table 2 lists the odds ratios (ORs) for each anthropomet-
ric measure from univariate and bivariate analyses for all
race–gender groups. In bivariate models, we singly
adjusted for each covariate to observe the risk effect on
the associations between the various anthropometric
measures and T2DM. The highest ORs were observed
for WHR in every race and gender group in the univa-
riate and bivariate analyses. The ABSI had the lowest
ORs among White and Black males and White females,
whereas BAI had the lowest ORs among Black females.
Multivariate associations of anthropometric measures and
T2DM
Table 3 lists the ORs from multivariate analyses for each
race–gender group. In general, the largest ORs for
T2DM across race and gender groups were for anthro-
pometric measures that included WC alone or relative
to height or hip circumference (i.e. WC, WHtR, and
WHR). The WHR had the highest adjusted ORs for
White and Black males and females, whereas ABSI was
the poorest anthropometric discriminator of T2DM, as
observed by its highest AIC and lowest ROC C-statistic
for all race–gender groups. In addition, ABSI had the
lowest ORs for all race–gender groups except for Black
females. The WHtR consistently displayed best ﬁt
indices for T2DM, as indicated by the lowest AIC and
highest ROC C-statistic values among White males,
whereas WHR had the best ﬁt for Black males, White
females, and Black females. However, as indicated in
Table 3, BMI, WC, WHtR, and WHR did not differ sig-
niﬁcantly in their ability to discriminate T2DM among
White males (P=0.2422) and Black males (P=0.5146).
Furthermore, although WHR had the best ﬁt AIC and
ROC indices for T2DM among White and Black fe-
males, WC and WHtR had comparable discriminatory
ability as WHR among White females (P=0.9495).
The WHR was the best anthropometric discriminator
among Black females (P< 0.0001). Generally, these dis-
criminators were stronger than ABSI and BAI in
predicting T2DM (P< 0.0001). Among White males,
covariate-adjusted ABSI did not perform better than co-
variates alone in discriminating between T2DM cases
from non-cases (P=0.3731). These ROC curves are
shown in Fig. 1.
We further investigated case identiﬁer values associ-
ated with T2DM for each anthropometric measure
within race–gender groups, as indicated in Table 3. In
general, Black males and Black females had lower case
identiﬁer values than their White counterparts. For ex-
ample, the case identiﬁer values for WHR were 0.97
for White males, 0.93 for Black males, 0.94 for White fe-
males, and 0.92 for Black females. We made no attempt
to compare across race or gender groups because the pri-
mary interest of the present study was within rather than
across groups.
Discussion
We found that anthropometric measures that included
WC alone or WC relative to height or hip circumference
(i.e. WHtR and WHR) were the strongest discriminators
of T2DM across race–gender groups studied. Waist cir-
cumference, WHtR, and WHR were the best discrimina-
tors of T2DM among White females, whereas WHR was
a superior discriminator among Black females. Among
White and Black males, BMI, WC, WHtR, and WHR
were comparable in their ability to discriminate
T2DM. The ABSI was the weakest anthropometric dis-
criminator of T2DM across all race–gender groups, ex-
cept for Black females. In general, the anthropometric
values identifying T2DM cases from non-cases were
lower for Blacks than Whites.
Anthropometric measures are useful screening tools
for T2DM, obesity, and other cardiometabolic condi-
tions because they are inexpensive and easily accessible.
In the present cross-sectional study, several anthropo-
metric measures had comparable ability in discriminat-
ing risk for T2DM. These results agree with other
studies that reported similar ﬁndings among US Whites.
Wang et al.41 found in the Health Professionals Follow-
up study, which consisted of predominantly White
males, that WC had the highest ROC C-statistic and
was similar in discrimination with BMI, but better than
WHR in predicting risk for T2DM. Mbanya et al.42
reported that WC and, to a lesser extent, WHtR were
stronger than BMI and WHR in their ability to dis-
criminate T2DM in a Cameroonian population. Xiao
et al.43 found that WHtR was the best discriminator of
T2DM and had the highest correlation with blood glu-
cose measures among Chinese males and females com-
pared with BMI, WC, WHR, and the poorest
discriminator BAI.
In meta-analyses, WHtR was found to be a better dis-
criminator of T2DM and other cardiovascular risk fac-
tors than WC and BMI in men and women in the
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Caribbean, Asia, Europe, Australia, North America,
South America, and the Middle East.17,22,44 However,
in another meta-analysis, WC or WHR were better
discriminators of T2DM cases in cross-sectional studies,
whereas longitudinal studies favored BMI, WC, WHtR,
or WHR.12 Other studies showed that WHtR and WHR
were better discriminators of dyslipidemia, metabolic
syndrome, and coronary heart disease than BMI.17,23,45
Although higher values of all anthropometric mea-
sures were associated with increased risk of T2DM in
our sample, ABSI, the newest anthropometric measure,
was the worst discriminator of T2DM across race–
gender groups, except among Black females. Fujita
et al.32 found ABSI to be weaker than WC and BMI
for predicting T2DM, high blood pressure, and dyslipi-
demia among Japanese adults. He et al.11 investigated
ABSI in a Chinese population and reported that ABSI
was associated with risk for T2DM, but that WC had
better discriminatory power than BMI or ABSI.
Similarly, Song et al.30 found that BMI and ABSI were
weaker discriminators than other anthropometric
measures for predicting cardiovascular disease mortality
among Europeans. Cheung31 reported that, in an
Indonesian sample, ABSI was less strongly associated
with incident high blood pressure than BMI and WC
and was the poorest discriminator compared with BMI,
WC, WHtR, WHR, and hip circumference. Abete
et al.33 found that WC, WHR, and ABSI were associated
with stroke in Spanish European men, whereas BMI
showed no association.
The case identiﬁer values in the present study were
used to distinguish T2DM cases from non-cases. These
values are not meant to reﬂect cut-off points that deﬁne
T2DM disease risk. The World Health Organization
(WHO) cut-off points25 were developed to reﬂect the risk
of developing T2DM, metabolic syndrome, high blood
pressure, and cardiovascular disease. Cut-off points
recommended by the WHO are based on relationships
between adiposity and disease risk while allowing for
global use and region-speciﬁc differences.25 For exam-
ple, Asians have lower BMI cut-off points that are
associated with the risk of developing T2DM46 and
lower WHR values associated with metabolic risk
compared with Whites.25 The WHO recommends
gender-speciﬁc cut-off points for WC and WHR to
identify risk for metabolic diseases.25
A limited number of studies have investigated race-
speciﬁc anthropometric cut-off points for Blacks. A study
of Caribbean Blacks in the UK suggested cut-off points
lower than for Whites, in agreement with the present
Figure 1 Receiver operating characteristic (ROC) curves in (a) White males, (b) Black males, (c) White females, and (d) Black females. The ROC
curves were constructed for type 2 diabetes mellitus as a response to each anthropometric measure (A body shape index [ABSI], body adiposity
index [BAI], body mass index BMI], waist circumference [WC], waist: height ratio [WHtR], and waist: hip ratio [WHR]) adjusting for covariates
(age, physical activity, and family history of diabetes) for White and Black American males and females.
Anthropometric discriminators of T2DM D.S. Hardy et al.
8
D.S. HARDY et al. Anthropometric discriminators of T2DM
© 2016 The Authors. Journal of Diabetes published by John Wiley & Sons Australia, Ltd and Ruijin Hospital, Shanghai Jiaotong University School of Medicine. 303
JDB_12416.indd   303 31/12/16   12:34 PM
study, but did not provide enough evidence to set speciﬁc
cut-off points by race within gender groups.47 In contrast,
other studies report higher cut-off points for Blacks than
Whites. Katzmarzyk et al.48 reported BMI and WC risk
identiﬁcation thresholds that were approximately
3 kg/m2 and 5 cm, respectively, higher in Black American
women than in White American women in a cross-
sectional study of cardiometabolic risk factors. Lutsey
et al.49 found that at the 95th percentile for WC, Black
Americans had a higher WC thanWhite Americans, Chi-
nese Americans, or Hispanic Americans (125 vs 121, 104,
and 121 cm, respectively. Frank et al.50 showed that
WHR was the best anthropometric discriminator of
T2DM for Ghanaian men and women, with optimal
cut-off points of ≥0.90 for men and ≥0.88 for women.
Blacks from different parts of the world have varying ge-
netic admixture, which may inﬂuence body shape, body
composition, and anthropometric measures.51 Therefore,
optimal anthropometric cut-off points for Blacks may
vary across different regions in the world.
The disagreement between studies regarding optimal
WC cut-off points is ongoing, and further longitudinal
data relating WC to T2DM risk are needed. Currently,
the International Diabetes Federation (IDF) and the
American Heart Association recommend the use of
population and region-speciﬁc WC guidelines.52 The
IDF Task Force on Epidemiology and Prevention, the
National Heart, Lung, and Blood Institute, the American
Heart Association, the World Heart Federation, the
International Atherosclerosis Society, and the Interna-
tional Association for the Study of Obesity issued a Joint
Scientiﬁc Statement on guidelines for metabolic syn-
drome that recognize that WC cut-off points of 80 cm
for women and 94 cm for men are associated with higher
risk of developing T2DM and cardiovascular disease.53
Case identiﬁer values in the present ARIC sample were
higher than the WHO cut-off points, likely because our
cases already had T2DM and were at risk long before
its development. These values are not meant to identify
the earliest onset of T2DM, but to distinguish between
individuals with and without T2DM in our sample.
Because the anthropometric case identiﬁer values in the
present study were lower for Black Americans than
White Americans, further research is needed to identify
race- and gender-speciﬁc cut-off points for each anthro-
pometric measure.
In the present study, and in general, Black Americans
had a higher proportion of diagnosed T2DM and were
heavier than White Americans. Type 2 diabetes mellitus
is a metabolic condition that develops over time and is as-
sociated with higher anthropometric values. Most of the
anthropometric case identiﬁer values associated with
T2DM risk in the present study were lower for Blacks
than Whites, except for BMI in Black females. The risk
of T2DM and other cardiometabolic risks have been
reported to develop at a BMI lower than 25 kg/m2, which
is the BMI cut-off points for deﬁning overweight.54,55
This phenomenon has been observed in other studies,56,57
which reinforces the ﬁndings of the present study.
The present study has limitations and advantages. A
potential limitation is the cross-sectional rather than
longitudinal design, so issues in temporality may sur-
face. Another potential limitation was the measurement
of WC at the umbilicus in the ARIC protocol,37 which
differs from the sites commonly use in the other epide-
miologic studies (e.g. superior border of the iliac
crest).58,59 Because approximately one-third of the US
population with T2DM is undiagnosed, there may be
some misclassiﬁcation of individuals with T2DM in
the ARIC cohort that may have biased our effect
estimates towards the null. In addition, we did not take
into consideration whether individuals in our sample
had prediabetes, (i.e. blood glucose values between
normal and the cut-off point for diabetes). Another
limitation is that individuals in our sample who were
categorized as having T2DM, but whose blood glucose
levels were well controlled, may have had anthropomet-
ric measures that are more reﬂective of individuals
without T2DM. For example, they may have been
more physically active, consumed a healthier die, or
taken medications regularly, and, as such, their meta-
bolic markers may have been similar to those of indi-
viduals without T2DM. An advantage of the present
study is the large sample size, with representation from
four race–gender groups. In addition, the anthropomet-
ric measures were obtained at the same anatomical sites
for all participants, with high methodological quality
control.
In summary, in evaluating the predictive ability of
several anthropometric discriminators, there was not a
single measure that was superior to all others among
White and Black Americans in the US, except for Black
females. In general, however, WC alone or expressed
relative to height (WHtR) or hip (WHR) circumference
performed the best in discriminating T2DM among
White and Black males and females. Body mass index
was a comparable discriminator among American males
but not American females. Importantly, the risk of
T2DM increased with higher values for all anthropomet-
ric measures among all race–gender groups. Because
there is no consensus agreement to identity optimal
anthropometric cut-off points for Black Americans,
further longitudinal research is needed to identify the
optimal anthropometric measures and their correspon-
ding cut-off points to discriminate T2DM risk for each
race–gender.
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